The authors have proposed that OCT1 physically interacts with the proinflammatory nuclear factor kappa-B (NF-κB) at an adjacent binding site, inhibiting its transactivating effects and affecting the susceptibility to IBD [34]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.